Meeting regulatory requirements in a fraction of the time
Discover your next small molecule drug product and get it to market faster, eliminating risks and meeting regulatory requirements in a fraction of the time.
- Work with industry experts to define your candidate profile and establish a purposeful screening cascade.
- Develop predictive translational biology models to understand clinical efficacy of your candidate.
- Use enhanced analytical methods to fail candidates fast or accelerate development.
- Optimize leads to define the path for success.
When you’re in the business of small molecule drug discovery, speed is everything. No one can afford to spend time developing a drug that won’t make it to market. You have to act quickly to find a large number of potential candidates and then drop them fast, selecting only the most promising to make it to the development stages.
Knowledge is everything and in this fast-paced environment, drug discovery must be lean, targeted, dynamic and based on sound data analytics. But, with stretched resources, difficulties in deciphering multiparameter datasets and team members pulled in many directions, time slips away.
This leads to project stagnation, a lack of data, a difficult decision-making process and ultimately late-stage failures. And the later they are, the more expensive they become.
There is another way…
By combining a dynamic mixture of:
- Medicinal, regulatory and industry experts that can work flexibly and as closely with your team as needed.
- A dedicated project management approach with a singular focus on getting your drug to market in the quickest way possible.
- Powerful AI-driven drug identification and optimization technology.
Suddenly, drug discovery is very much closer to market launch.
Take a deep dive into each of our drug discovery services: